MedPath

To determine whether 3 doses of vaccines for rabies post exposure prophylaxis are enough to protect against the development of the disease

Not Applicable
Conditions
Health Condition 1: W540- Bitten by dog
Registration Number
CTRI/2023/08/056607
Lead Sponsor
Department of Pediatrics
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children and adolescents under 18 years of age presenting for the fourth dose of rabies post exposure prophylaxis

Exclusion Criteria

1.known case of immunodeficiency states.

2.history of receiving any dose of anti rabies vaccine prior to current animal exposure.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of children with IgG anti rabies virus glycoprotein titres equal to or more than 0.5 EU/ml after 3 doses of Intradermal post exposure rabies prophylaxis in children & adolescents under 18 years of ageTimepoint: day 28 of rabies post exposure prophylaxis
Secondary Outcome Measures
NameTimeMethod
adverse events following 3 doses of intradermal post exposure rabies prophylaxisTimepoint: on day 28 of rabies post exposure prophylaxis
© Copyright 2025. All Rights Reserved by MedPath